Validation of the SF-6D health state utilities measure in lower extremity sarcoma

Sarcoma

Volumn 2014, Issue , 2014, Pages

  Gundle, Kenneth R ^a   Cizik, Amy M ^a   Punt, Stephanie E W ^a   Conrad, Ernest U ^a   Davidson, Darin J ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; CONVERGENT VALIDITY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATOR; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LEG; LEG AMPUTATION; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; SARCOMA; SHORT FORM 36; SHORT FORM 6D HEALTH STATE UTILITIES MEASURE; WALKING AID;

EID: 84897516929     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2014/450902     Document Type: Article

References (21)

1. Basch E., Abernethy A. P., Mullins C. D., Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. Journal of Clinical Oncology 2012 30 34 4249 4255
2. Ware J. E., Snow K. K., Kosinski M., Gandek B., New England Medical Center Hospital 1993 Cambridge, Mass, USA Health Institute SF-36 Health Survey
3. Patel A. A., Donegan D., Albert T., The 36-item short form. Journal of the American Academy of Orthopaedic Surgeons 2007 15 2 126 134
4. Kopec J. A., Willison K. D., A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology 2003 56 4 317 325 2-s2.0-0038628838 10.1016/S0895-4356(02) 00609-1 (Pubitemid 36593310)
5. Shaw J. W., Johnson J. A., Coons S. J., US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care 2005 43 3 203 220 2-s2.0-14844319324 10.1097/00005650-200503000-00003 (Pubitemid 40353904)
6. Torrance G. W., Measurement of health state utilities for economic appraisal: a review. Journal of Health Economics 1986 5 1 1 30 2-s2.0-0022633115 (Pubitemid 16098443)
7. Parthan A., Kruse M., Yurgin N., Huang J., Viswanathan H. N., Taylor D., Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US. Appl Health Econ Health Policy 2013 11 5 485 497
8. Solomon D. H., Patrick A. R., Schousboe J., Losina E., The potential economic benefits of improved post-fracture care: a cost-effectiveness analysis of a fracture liaison service in the US health care system. Journal of Bone and Mineral Research 2014 10.1002/jbmr.2180
9. Stewart A. L., Hays R. D., Ware J. E. Jr., The MOS short-form general health survey. Reliability and validity in a patient population. Medical Care 1988 26 7 724 735 2-s2.0-0024042879
10. Brazier J., Roberts J., Deverill M., The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 2002 21 2 271 292 2-s2.0-0036169017 10.1016/S0167-6296(01)00130-8 (Pubitemid 34143147)
11. Kharroubi S. A., Brazier J. E., Roberts J., O'Hagan A., Modelling SF-6D health state preference data using a nonparametric Bayesian method. Journal of Health Economics 2007 26 3 597 612 2-s2.0-34147166155 10.1016/j.jhealeco.2006. 09.002 (Pubitemid 46562487)
12. Bhinder S., Chowdhury N., Granton J., Krahn M., Tullis D. E., Waddell T. K., Singer L. G., Feasibility of internet-based health-related quality of life data collection in a large patient cohort. Journal of Medical Internet Research 2010 12 3 e35 2-s2.0-77957593768 10.2196/jmir.1214
13. Davis A. M., Wright J. G., Williams J. I., Bombardier C., Griffin A., Bell R. S., Development of a measure of physical function for patients with bone and soft tissue sarcoma. Quality of Life Research 1996 5 5 508 516 2-s2.0-0029849710 10.1007/BF00540024 (Pubitemid 26382286)
14. Atroshi I., Gummesson C., McCabe S. J., Ornstein E., The SF-6D health utility index in carpal tunnel syndrome. Journal of Hand Surgery 2007 32 2 198 202 2-s2.0-33847394643 10.1016/j.jhsb.2006.11.002 (Pubitemid 46335597)
15. Tosh J., Brazier J., Evans P., Longworth L., A review of generic preference-based measures of health-related quality of life in visual disorders. Value in Health 2012 15 1 118 127 2-s2.0-84855988939 10.1016/j.jval.2011.08.002
16. Brazier J., Roberts J., Tsuchiya A., Busschbach J., A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics 2004 13 9 873 884 2-s2.0-4644372794 10.1002/hec.866 (Pubitemid 39264234)
17. Brooks R., de Charro F., EuroQol: the current state of play. Health Policy 1996 37 1 53 72 2-s2.0-0029952658 10.1016/0168-8510(96)00822-6 (Pubitemid 26191458)
18. Szende A., Leidy N. K., Ståhl E., Svensson K., Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Quality of Life Research 2009 18 2 267 272 2-s2.0-59849125574 10.1007/s11136-008-9429-z
19. Sach T. H., Barton G. R., Jenkinson C., Doherty M., Avery A. J., Muir K. R., Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Medical Care 2009 47 8 889 894 2-s2.0-68249151147 10.1097/MLR.0b013e3181a39428
20. Pickard A. S., De Leon M. C., Kohlmann T., Cella D., Rosenbloom S., Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care 2007 45 3 259 263 2-s2.0-33847200473 10.1097/01.mlr. 0000254515.63841.81
21. Whitehurst D. G. T., Bryan S., Lewis M., Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Medical Decision Making 2011 31 6 E34 E44 2-s2.0-80955157844 10.1177/0272989X11421529